ENANTA PHARMACEUTICALS INC — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Capps Kathleen S. | See Remarks | Sale | 323 | $14.23 | $4,596 | 8,377 | Dec 5, 2025 |
| Trout Harry R. III | See Remarks | Sale | 542 | $14.23 | $7,713 | 16,348 | Dec 5, 2025 |
| Rottinghaus Scott T. | Chief Medical Officer | Sale | 798 | $14.23 | $11,356 | 21,792 | Dec 5, 2025 |
| Luu Brendan | Chief Business Officer | Sale | 1,394 | $14.23 | $19,837 | 38,329 | Dec 5, 2025 |
| Kieffer Tara Lynn | Chief Product Strategy Officer | Sale | 2,106 | $14.23 | $29,968 | 30,620 | Dec 5, 2025 |
| Or Yat Sun | Chief Scientific Officer | Sale | 2,390 | $14.23 | $34,010 | 371,392 | Dec 5, 2025 |
| Luly Jay R. | President and CEO | Sale | 4,743 | $14.23 | $67,493 | 858,026 | Dec 5, 2025 |
| Capps Kathleen S. | See Remarks | Tax Withholding | 85 | $14.12 | $1,200 | 8,907 | Dec 2, 2025 |
| Trout Harry R. III | See Remarks | Tax Withholding | 105 | $14.12 | $1,483 | 17,270 | Dec 2, 2025 |
| Luu Brendan | Chief Business Officer | Tax Withholding | 498 | $14.12 | $7,032 | 39,723 | Dec 1, 2025 |
| Kieffer Tara Lynn | Chief Product Strategy Officer | Tax Withholding | 753 | $14.12 | $10,632 | 32,726 | Dec 1, 2025 |
| Or Yat Sun | Chief Scientific Officer | Tax Withholding | 753 | $14.12 | $10,632 | 373,782 | Dec 1, 2025 |
| Luly Jay R. | President and CEO | Tax Withholding | 1,885 | $14.12 | $26,616 | 862,769 | Dec 1, 2025 |
| Capps Kathleen S. | See Remarks | Award / Grant | 3,163 | — | — | 8,992 | Nov 25, 2025 |
| Trout Harry R. III | See Remarks | Award / Grant | 6,463 | — | — | 17,375 | Nov 25, 2025 |
| Rottinghaus Scott T. | Chief Medical Officer | Tax Withholding | 2,217 | $6.99 | $15,497 | 22,590 | Aug 8, 2025 |
| Luu Brendan | Chief Business Officer | Tax Withholding | 3,326 | $5.59 | $18,592 | 40,221 | Feb 12, 2025 |
| Kieffer Tara Lynn | Chief Product Strategy Officer | Tax Withholding | 3,326 | $5.59 | $18,592 | 33,479 | Feb 12, 2025 |
| Rottinghaus Scott T. | Chief Medical Officer | Tax Withholding | 2,861 | $5.59 | $15,993 | 24,807 | Feb 12, 2025 |
| Or Yat Sun | Chief Scientific Officer | Award / Grant | 9,750 | — | — | 378,859 | Feb 12, 2025 |
| MELLETT PAUL J | Chief Fin. & Admin Officer | Award / Grant | 7,500 | — | — | 99,210 | Feb 12, 2025 |
| Luly Jay R. | President and CEO | Tax Withholding | 7,484 | $5.59 | $41,836 | 864,654 | Feb 12, 2025 |
| Luly Jay R. | President and CEO | Purchase | 45,000 | $5.69 | $256,050 | 846,638 | Feb 12, 2025 |
| Kieffer Tara Lynn | Chief Product Strategy Officer | Sale | 2,283 | $8.06 | $18,401 | 29,305 | Dec 6, 2024 |
| Luu Brendan | Chief Business Officer | Sale | 2,283 | $8.06 | $18,401 | 36,047 | Dec 6, 2024 |
| Rottinghaus Scott T. | Chief Medical Officer | Sale | 866 | $8.06 | $6,980 | 17,918 | Dec 6, 2024 |
| Or Yat Sun | Chief Scientific Officer | Sale | 2,591 | $8.06 | $20,883 | 369,109 | Dec 6, 2024 |
| MELLETT PAUL J | Chief Fin. & Admin Officer | Sale | 2,591 | $8.06 | $20,883 | 91,710 | Dec 6, 2024 |
| Luly Jay R. | President and CEO | Sale | 5,142 | $8.06 | $41,445 | 801,638 | Dec 6, 2024 |
| Luu Brendan | Chief Business Officer | Tax Withholding | 753 | $8.60 | $6,476 | 38,330 | Dec 1, 2024 |
| Kieffer Tara Lynn | Chief Product Strategy Officer | Tax Withholding | 753 | $8.60 | $6,476 | 31,588 | Dec 1, 2024 |
| Or Yat Sun | Chief Scientific Officer | Tax Withholding | 1,595 | $8.60 | $13,717 | 371,700 | Dec 1, 2024 |
| MELLETT PAUL J | Chief Fin. & Admin Officer | Tax Withholding | 1,595 | $8.60 | $13,717 | 94,301 | Dec 1, 2024 |
| Luly Jay R. | President and CEO | Tax Withholding | 3,829 | $8.60 | $32,929 | 806,780 | Dec 1, 2024 |
| Rottinghaus Scott T. | Chief Medical Officer | Option Exercise | 5,375 | $8.99 | $48,321 | 27,092 | Jul 11, 2024 |
| Kieffer Tara Lynn | Chief Product Strategy Officer | Sale | 7,266 | $12.33 | $89,590 | 32,341 | Jun 17, 2024 |
| Gardiner Nathaniel S. | Chief Legal Officer | Option Exercise | 5,187 | $8.99 | $46,631 | 75,688 | Feb 26, 2024 |
| Luu Brendan | Chief Business Officer | Tax Withholding | 973 | $12.41 | $12,075 | 39,083 | Feb 12, 2024 |
| Kieffer Tara Lynn | Chief Product Strategy Officer | Award / Grant | 3,320 | — | — | 40,580 | Feb 12, 2024 |
| Gardiner Nathaniel S. | Chief Legal Officer | Award / Grant | 3,320 | — | — | 71,474 | Feb 12, 2024 |
| Rottinghaus Scott T. | Chief Medical Officer | Award / Grant | 2,576 | — | — | 29,042 | Feb 12, 2024 |
| Or Yat Sun | Chief Scientific Officer | Tax Withholding | 1,080 | $12.41 | $13,403 | 373,295 | Feb 12, 2024 |
| MELLETT PAUL J | Chief Fin. & Admin Officer | Award / Grant | 3,320 | — | — | 96,869 | Feb 12, 2024 |
| Luly Jay R. | President and CEO | Award / Grant | 5,400 | — | — | 812,193 | Feb 12, 2024 |
| Vance Terry | — | Sale | 15,295 | $9.12 | $139,490 | 5,800 | Dec 13, 2023 |
| Luu Brendan | Sr. VP, Business Dev. | Sale | 2,125 | $9.63 | $20,464 | 36,736 | Dec 5, 2023 |
| Kieffer Tara Lynn | Sr. VP, New Prod. Strat. & Dev | Sale | 2,125 | $9.63 | $20,464 | 37,260 | Dec 5, 2023 |
| Gardiner Nathaniel S. | Sr. VP & General Counsel | Sale | 2,412 | $9.63 | $23,228 | 68,154 | Dec 5, 2023 |
| Rottinghaus Scott T. | Sr. VP & CMO | Sale | 534 | $9.63 | $5,142 | 26,466 | Dec 5, 2023 |
| Or Yat Sun | Sr. VP, R&D & CSO | Sale | 2,412 | $9.63 | $23,228 | 370,695 | Dec 5, 2023 |